FMP
KraneShares Emerging Markets Healthcare Index ETF
KMED
AMEX
Inactive Equity
The fund will invest at least 80% of its net assets in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index includes companies that RBICS classifies as engaged in the pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services and services to the health industry businesses. The fund is non-diversified.
18.81 USD
-0.5902 (-3.14%)
Operating Data
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
6.43B
7.88B
7.56B
7.43B
7.31B
7.58B
7.87B
8.16B
8.47B
8.79B
Revenue %
-
22.51
-4.09
-1.73
-1.64
3.76
3.76
3.76
3.76
Ebitda
2.08B
2.17B
1.61B
1.55B
1.62B
1.88B
1.96B
2.03B
2.11B
2.18B
Ebitda %
32.25
27.58
21.35
20.89
22.2
24.85
24.85
24.85
24.85
Ebit
1.55B
1.81B
1.39B
1.28B
1.34B
1.53B
1.59B
1.65B
1.71B
1.78B
Ebit %
24.15
22.98
18.43
17.27
18.34
20.23
20.23
20.23
20.23
Depreciation
521M
363M
221M
269M
282M
350.38M
363.56M
377.23M
391.42M
406.15M
Depreciation %
8.1
4.61
2.92
3.62
3.86
4.62
4.62
4.62
4.62
Balance Sheet
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Total Cash
3.9B
1.98B
1.23B
1.08B
674M
1.91B
1.98B
2.06B
2.13B
2.21B
Total Cash %
60.66
25.11
16.3
14.59
9.22
25.18
25.18
25.18
25.18
Receivables
148M
240M
226M
224M
205M
214.65M
222.72M
231.1M
239.79M
248.81M
Receivables %
2.3
3.04
2.99
3.02
2.81
2.83
2.83
2.83
2.83
Inventories
1.27B
709M
709M
710M
734M
875.87M
908.82M
943M
978.47M
1.02B
Inventories %
19.79
9
9.38
9.56
10.05
11.55
11.55
11.55
11.55
Payable
345M
435M
455M
380M
338M
403.97M
419.16M
434.93M
451.28M
468.26M
Payable %
5.36
5.52
6.02
5.12
4.63
5.33
5.33
5.33
5.33
Cap Ex
-228M
-270M
-328M
-298M
-226M
-279.19M
-289.7M
-300.59M
-311.9M
-323.63M
Cap Ex %
-3.54
-3.43
-4.34
-4.01
-3.09
-3.68
-3.68
-3.68
-3.68
Weighted Average Cost Of Capital
Price
26.64
Beta
Diluted Shares Outstanding
219M
Costof Debt
6.29
Tax Rate
After Tax Cost Of Debt
4.88
Risk Free Rate
Market Risk Premium
Cost Of Equity
Total Debt
4.96B
Total Equity
5.83B
Total Capital
10.79B
Debt Weighting
45.95
Equity Weighting
54.05
Wacc
8.87
Build Up Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
6.43B
7.88B
7.56B
7.43B
7.31B
7.58B
7.87B
8.16B
8.47B
8.79B
Ebitda
2.08B
2.17B
1.61B
1.55B
1.62B
1.88B
1.96B
2.03B
2.11B
2.18B
Ebit
1.55B
1.81B
1.39B
1.28B
1.34B
1.53B
1.59B
1.65B
1.71B
1.78B
Tax Rate
22.37
22.37
22.37
22.37
22.37
22.37
22.37
22.37
22.37
22.37
Ebiat
1.17B
1.7B
1.07B
1.1B
1.04B
1.26B
1.3B
1.35B
1.4B
1.45B
Depreciation
521M
363M
221M
269M
282M
350.38M
363.56M
377.23M
391.42M
406.15M
Receivables
148M
240M
226M
224M
205M
214.65M
222.72M
231.1M
239.79M
248.81M
Inventories
1.27B
709M
709M
710M
734M
875.87M
908.82M
943M
978.47M
1.02B
Payable
345M
435M
455M
380M
338M
403.97M
419.16M
434.93M
451.28M
468.26M
Cap Ex
-228M
-270M
-328M
-298M
-226M
-279.19M
-289.7M
-300.59M
-311.9M
-323.63M
Ufcf
385.96M
2.35B
993.41M
1B
1.05B
1.24B
1.35B
1.4B
1.45B
1.51B
Wacc
8.87
8.87
8.87
8.87
8.87
Pv Ufcf
1.14B
1.14B
1.09B
1.03B
986.27M
Sum Pv Ufcf
5.39B
Terminal Value
Growth In Perpetuity Method
Long Term Growth Rate
Wacc
8.87
Free Cash Flow T1
1.52B
Terminal Value
19.36B
Present Terminal Value
12.65B
Intrinsic Value
Enterprise Value
18.04B
Net Debt
4.29B
Equity Value
13.75B
Diluted Shares Outstanding
219M
Equity Value Per Share
62.8
Projected DCF
62.8 0.576%
